phrykt

Phibro Animal Health Corp (PAHC): who owns it and who trades it

As of Nov 16, 2026, PAHC insiders reported 97 open-market sales worth $24.6M and 1 purchase worth $318K in the last 12 months, with 100% of the sale value made under pre-set 10b5-1 plans. The largest seller was Jack Bendheim (CEO), with $12.4M. 4 of the 50 famous funds we follow held it at their last quarter end.

Latest filing Nov 16, 2026. From Form 4, 13F and Schedule 13D/G filings.

At a glance

Who is buying and selling Phibro Animal Health

From the latest filings

Overall: more buying than selling. Insiders mostly bought. Funds and famous investors were close to even.

Mostly sellingEvenMostly buying

Each group counts equally in the meter, by the number of buyers and sellers, not dollars. Insider sales under pre-set 10b5-1 plans are left out of it. From SEC, House and Senate filings; not advice.

Who owns PAHC

209 funds and institutions reported PAHC shares worth $696M at the end of Q2 2026. The largest holder is BlackRock, Inc. with $101M.

10 largest owners, by value

BlackRock, Inc.$101M
FMR LLC (Fidelity)$99.2M
State Street Corp$32.6M
Millennium Management LLC$29.4M
Vanguard Capital Management LLC$29M
California State Teachers Retirement System$28.4M
Geode Capital Management, LLC$20.6M
Lord, Abbett & Co. LLC$20.5M
Dimensional Fund Advisors LP$16.7M
Vanguard Portfolio Management LLC$16M

Top 20 owners

OwnerShares% of companyValueChange since Q1 2026
BlackRock, Inc.3.22M–$101M-1%
FMR LLC (Fidelity)3.16M–$99.2M+45%
State Street Corp1.04M–$32.6M+9%
Millennium Management LLC936,701–$29.4M+1578%
Vanguard Capital Management LLC923,318–$29M+4%
California State Teachers Retirement System891,980–$28.4M+3862%
Geode Capital Management, LLC657,350–$20.6M+9%
Lord, Abbett & Co. LLC653,305–$20.5M+64%
Dimensional Fund Advisors LP531,087–$16.7M+5%
Vanguard Portfolio Management LLC508,486–$16M+4%
Renaissance Technologies LLC480,500–$15.1M-17%
CastleKnight Management LP461,322–$14.5M+508%
Morgan Stanley412,634–$13M+5%
Dana Investment Advisors, Inc.387,867–$12.2M+35%
Invesco Ltd.336,329–$10.6M+2%
Nuveen, LLC314,079–$9.9M-31%
Oberweis Asset Management Inc/311,100–$9.8M+12%
Ranger Investment Management, L.P.292,410–$9.2M+5%
Charles Schwab Investment Management Inc260,861–$8.2M-1%
Sixth Street Partners Management Company, L.P.260,861–$8.2M–

From the SEC 13F data sets: every fund manager with over $100M must report its US stock holdings every 3 months, up to 45 days after the quarter ends. Owners are shown as they file, so one group (for example Vanguard) can appear under several names. Individuals, most insiders and smaller funds do not file 13F reports.

Insider trades

In the last 12 months, PAHC insiders reported $318K of open-market purchases and $24.6M of sales. 100% of the sale value was under a 10b5-1 plan, a schedule set up in advance.

Purchases, 12 months
$318K
1 trades, 1 people
Sales, 12 months
$24.6M
97 trades, 2 people
Sales under a 10b5-1 plan
100%
Share of sale value
Latest trade
May 29, 2026
Filed Jun 2, 2026

Purchases and sales by month

$12.2M$12.2MDecFebAprJunAugOct
Purchases Sales Click a bar to show only that month below

Latest trades

DateInsiderRoleTypeSharesPriceValueFiling
May 29, 2026E Thomas CorcoranDirectorPurchase10,000$31.77$318KForm 4
May 7, 2026Jack Bendheim +1CEOSale plan2,029$49.19$99.8KForm 4
May 7, 2026Jack Bendheim +1CEOSale plan1,149$48.31$55.5KForm 4
May 7, 2026Jack Bendheim +1CEOSale plan1,350$47.59$64.2KForm 4
May 6, 2026Jack Bendheim +1CEOSale plan5,634$57.18$322KForm 4
May 6, 2026Jack Bendheim +1CEOSale plan1,406$58.13$81.7KForm 4
May 5, 2026Jack Bendheim +1CEOSale plan6,264$55.73$349KForm 4
May 5, 2026Jack Bendheim +1CEOSale plan776$56.37$43.7KForm 4
Apr 30, 2026Jack Bendheim +1CEOSale plan1,235$53.32$65.9KForm 4
Apr 30, 2026Jack Bendheim +1CEOSale plan5,805$52.65$306KForm 4
Apr 29, 2026Jack Bendheim +1CEOSale plan3,038$53.21$162KForm 4
Apr 29, 2026Jack Bendheim +1CEOSale plan4,002$52.70$211KForm 4
Apr 28, 2026Jack Bendheim +1CEOSale plan4,591$56.06$257KForm 4
Apr 28, 2026Jack Bendheim +1CEOSale plan1,652$55.10$91KForm 4
Apr 28, 2026Jack Bendheim +1CEOSale plan797$56.69$45.2KForm 4
Apr 23, 2026Jack Bendheim +1CEOSale plan421$54.56$23KForm 4
Apr 23, 2026Jack Bendheim +1CEOSale plan6,619$54.07$358KForm 4
Apr 22, 2026Jack Bendheim +1CEOSale plan7,040$54.29$382KForm 4
Apr 21, 2026Jack Bendheim +1CEOSale plan1,625$55.35$89.9KForm 4
Apr 21, 2026Jack Bendheim +1CEOSale plan5,415$56.17$304KForm 4
Apr 16, 2026BFI Co., LLC +110% ownerSale plan5,190$54.56$283KForm 4
Apr 16, 2026BFI Co., LLC +110% ownerSale plan1,850$54.88$102KForm 4
Apr 15, 2026BFI Co., LLC +110% ownerSale plan2,623$56.27$148KForm 4
Apr 15, 2026BFI Co., LLC +110% ownerSale plan3,618$57.21$207KForm 4
Apr 15, 2026BFI Co., LLC +110% ownerSale plan799$58.11$46.4KForm 4
Apr 14, 2026BFI Co., LLC +110% ownerSale plan6,548$59.03$387KForm 4
Apr 14, 2026BFI Co., LLC +110% ownerSale plan492$59.69$29.4KForm 4
Mar 31, 2026Jack Bendheim +1CEOSale plan6,609$53.87$356KForm 4
Mar 31, 2026Jack Bendheim +1CEOSale plan431$54.35$23.4KForm 4
Mar 30, 2026Jack Bendheim +1CEOSale plan6,423$53.54$344KForm 4
Mar 30, 2026Jack Bendheim +1CEOSale plan617$54.31$33.5KForm 4
Mar 26, 2026Jack Bendheim +1CEOSale plan6,760$56.79$384KForm 4
Mar 26, 2026Jack Bendheim +1CEOSale plan280$57.17$16KForm 4
Mar 25, 2026Jack Bendheim +1CEOSale plan4,916$56.00$275KForm 4
Mar 25, 2026Jack Bendheim +1CEOSale plan552$56.86$31.4KForm 4
Mar 25, 2026Jack Bendheim +1CEOSale plan1,572$55.28$86.9KForm 4
Mar 24, 2026Jack Bendheim +1CEOSale plan6,523$52.88$345KForm 4
Mar 24, 2026Jack Bendheim +1CEOSale plan517$53.59$27.7KForm 4
Mar 19, 2026Jack Bendheim +1CEOSale plan124$53.24$6.6KForm 4
Mar 19, 2026Jack Bendheim +1CEOSale plan1,939$51.78$100KForm 4
Mar 19, 2026Jack Bendheim +1CEOSale plan4,977$52.79$263KForm 4
Mar 18, 2026Jack Bendheim +1CEOSale plan4,311$51.80$223KForm 4
Mar 18, 2026Jack Bendheim +1CEOSale plan3,598$53.03$191KForm 4
Mar 18, 2026Jack Bendheim +1CEOSale plan2,651$53.64$142KForm 4
Mar 17, 2026Jack Bendheim +1CEOSale plan5,280$51.66$273KForm 4
Mar 13, 2026Jack Bendheim +1CEOSale plan5,280$48.91$258KForm 4
Feb 26, 2026BFI Co., LLC +110% ownerSale plan711$54.28$38.6KForm 4
Feb 26, 2026BFI Co., LLC +110% ownerSale plan6,329$53.67$340KForm 4
Feb 25, 2026BFI Co., LLC +110% ownerSale plan7,040$51.71$364KForm 4
Feb 24, 2026BFI Co., LLC +110% ownerSale plan5,889$51.27$302KForm 4
Feb 24, 2026BFI Co., LLC +110% ownerSale plan1,151$51.88$59.7KForm 4
Feb 20, 2026BFI Co., LLC +110% ownerSale plan6,643$51.38$341KForm 4
Feb 20, 2026BFI Co., LLC +110% ownerSale plan397$51.96$20.6KForm 4
Feb 19, 2026BFI Co., LLC +110% ownerSale plan7,040$50.26$354KForm 4
Feb 18, 2026BFI Co., LLC +110% ownerSale plan216$51.97$11.2KForm 4
Feb 18, 2026BFI Co., LLC +110% ownerSale plan6,824$51.38$351KForm 4
Feb 13, 2026BFI Co., LLC +110% ownerSale plan7,040$51.96$366KForm 4
Feb 11, 2026Jack Bendheim +1CEOSale plan13,950$51.61$720KForm 4
Feb 11, 2026Jack Bendheim +1CEOSale plan234$52.21$12.2KForm 4
Feb 10, 2026Jack Bendheim +1CEOSale plan50,994$51.76$2.6MForm 4
Feb 10, 2026Jack Bendheim +1CEOSale plan7,020$52.17$366KForm 4
Feb 5, 2026BFI Co., LLC +110% ownerSale plan409$44.47$18.2KForm 4
Feb 5, 2026BFI Co., LLC +110% ownerSale plan3,640$45.42$165KForm 4
Feb 5, 2026BFI Co., LLC +110% ownerSale plan19,138$49.57$949KForm 4
Feb 5, 2026BFI Co., LLC +110% ownerSale plan46,275$48.65$2.3MForm 4
Feb 5, 2026BFI Co., LLC +110% ownerSale plan38,209$47.91$1.8MForm 4
Feb 5, 2026BFI Co., LLC +110% ownerSale plan3,171$46.68$148KForm 4
Feb 4, 2026Jack Bendheim +1CEOSale plan3,520$41.15$145KForm 4
Feb 3, 2026Jack Bendheim +1CEOSale plan6,689$41.25$276KForm 4
Feb 3, 2026Jack Bendheim +1CEOSale plan2,971$41.97$125KForm 4
Jan 30, 2026BFI Co., LLC +110% ownerSale plan6,693$40.09$268KForm 4
Jan 29, 2026BFI Co., LLC +110% ownerSale plan6,772$40.12$272KForm 4
Jan 23, 2026Jack Bendheim +1CEOSale plan1,235$40.55$50.1KForm 4
Jan 22, 2026Jack Bendheim +1CEOSale plan1,283$42.68$54.8KForm 4
Jan 22, 2026Jack Bendheim +1CEOSale plan11,875$41.91$498KForm 4
Jan 21, 2026Jack Bendheim +1CEOSale plan14,687$41.68$612KForm 4
Jan 15, 2026BFI Co., LLC +110% ownerSale plan2,932$40.02$117KForm 4
Jan 14, 2026BFI Co., LLC +110% ownerSale plan393$41.14$16.2KForm 4
Jan 14, 2026BFI Co., LLC +110% ownerSale plan3,258$40.46$132KForm 4
Jan 13, 2026BFI Co., LLC +110% ownerSale plan7,551$40.32$304KForm 4
Jan 9, 2026BFI Co., LLC +110% ownerSale plan213$40.16$8.6KForm 4
Jan 7, 2026Jack Bendheim +1CEOSale plan328$40.09$13.1KForm 4
Dec 11, 2025BFI Co., LLC +110% ownerSale plan2,757$40.61$112KForm 4
Dec 11, 2025BFI Co., LLC +110% ownerSale plan2,995$41.22$123KForm 4
Dec 9, 2025Jack Bendheim +1CEOSale plan1,288$40.19$51.8KForm 4
Dec 8, 2025Jack Bendheim +1CEOSale plan3,520$40.06$141KForm 4
Dec 4, 2025BFI Co., LLC +110% ownerSale plan3,152$41.16$130KForm 4
Dec 4, 2025BFI Co., LLC +110% ownerSale plan368$41.75$15.4KForm 4
Dec 3, 2025BFI Co., LLC +110% ownerSale plan3,520$40.77$144KForm 4
Dec 1, 2025BFI Co., LLC +110% ownerSale plan3,520$41.66$147KForm 4
Nov 28, 2025BFI Co., LLC +110% ownerSale plan3,520$42.54$150KForm 4
Nov 26, 2025BFI Co., LLC +110% ownerSale plan5,280$44.02$232KForm 4
Nov 25, 2025BFI Co., LLC +110% ownerSale plan7,040$43.93$309KForm 4
Nov 20, 2025BFI Co., LLC +110% ownerSale plan3,459$41.75$144KForm 4
Nov 20, 2025BFI Co., LLC +110% ownerSale plan61$42.32$2.6KForm 4
Nov 18, 2025BFI Co., LLC +110% ownerSale plan20$44.28$886Form 4
Nov 18, 2025BFI Co., LLC +110% ownerSale plan5,260$43.82$230KForm 4
Nov 17, 2025BFI Co., LLC +110% ownerSale plan5,280$44.56$235KForm 4

Insiders by value traded

InsiderRoleBoughtSoldLast trade
Jack BendheimPresident and CEO, Director, 10% owner–$12.4MMay 7, 2026
BFI Co., LLC10% owner–$12.2MApr 16, 2026
E Thomas CorcoranDirector$318K–May 29, 2026
What this data shows, and what it doesn't
  • Shows: open-market purchases and sales by officers, directors and 10%+ owners, reported on Form 4 within two business days of the trade.
  • Leaves out: stock awards, option exercises, shares withheld for tax and gifts. These are not trades at a market price chosen by the insider.
  • "plan" marks a sale made under a Rule 10b5-1 plan, a schedule set up in advance.
  • Fund holders come from 13F reports, a snapshot at quarter end filed up to 45 days later.
  • Filings are self-reported and can be amended. Each trade links to its original filing. Methodology

PAHC short interest

1.02M PAHC shares are sold short. Over the last 12 reports the number of shares short went down 14%.

As of Oct 30, 2026, 1.02M PAHC shares were sold short, down 1.3% from the report before. At the average daily volume of 158,839 shares, buying them all back would take about 6.4 trading days (days to cover).

Shares short

1.02MMay 15Oct 301.27M

Days to cover

6.4May 15Oct 308.1

Every report

Settlement dateShares short% of sharesChangeAvg daily volumeDays to cover
Oct 30, 20261.02M–-1%158,8396.4
Oct 15, 20261.03M–+1%239,4514.3
Sep 30, 20261.02M–-11%251,6294.1
Sep 15, 20261.14M–-6%233,5634.9
Aug 31, 20261.21M–-2%246,7614.9
Aug 14, 20261.23M–+3%169,7087.3
Jul 31, 20261.19M–-2%212,3865.6
Jul 15, 20261.22M–+0%320,2823.8
Jun 30, 20261.22M–-1%287,4464.2
Jun 15, 20261.23M–+12%355,5563.5
May 29, 20261.10M–-7%357,5823.1
May 15, 20261.18M–-3%584,0682.0

Short sellers borrow shares and sell them, hoping to buy them back for less. A high number means many such bets are open. It does not say where the price will go. Source: FINRA equity short interest, reported by brokers twice a month (positions on the 15th and the last business day) and published about 7 business days later. % of shares uses the share count on the company's latest SEC filing. What short interest means · Most shorted stocks

Phibro Animal Health company events

Phibro Animal Health filed 13 reports on Form 8-K in the last 12 months, 3 of them about an important change (leadership). The latest was on Nov 4, 2026.

  1. Nov 4, 2026ResultsReleased financial results. Filing
  2. Nov 3, 2026AnnouncementPhibro Animal Health Corporation issued a press release announcing the declaration of a quarterly cash dividend of $0.12 per share on its Class A common stock and Class B common stock, payable on December 16, 2026, to stockholders of record at the close of business on November 25, 2026. Filing
  3. Aug 26, 2026ResultsReleased financial results. Filing
  4. Jul 28, 2026AnnouncementPhibro Animal Health Corporation issued a press release announcing the declaration of a quarterly cash dividend of $0.12 per share on its Class A common stock and Class B common stock, payable on September 23, 2026, to stockholders of record at the close of business on September 2, 2026. Filing
  5. Jun 26, 2026LeadershipIn connection with Daniel (Dani) Bendheim’s appointment to the role of Chief Executive Officer and President of the Company effective July 1, 2026, the Compensation Committee of the Board of Directors of Phibro Animal Health Corporation approved (i) the Company’s entry into an employment agreement… Filing
  6. May 6, 2026ResultsReleased financial results. Filing
  7. May 5, 2026AnnouncementPhibro Animal Health Corporation issued a press release announcing the declaration of a quarterly cash dividend of $0.12 per share on its Class A common stock and Class B common stock, payable on June 24, 2026, to stockholders of record at the close of business on June 3, 2026. Filing
  8. Apr 30, 2026AgreementPhibro Animal Health Corporation entered into Amendment No. 1 to its Credit Agreement with Coöperatieve Rabobank U.A., New York Branch, as administrative agent, collateral agent and L/C issuer, and each lender from time to time party thereto, which amends the Credit Agreement, dated as of July 3… Filing
  9. Apr 27, 2026AnnouncementShared information with investors. Filing
  10. Apr 14, 2026LeadershipMs. Joyce J. Lee, a member of the Board of the Directors of Phibro Animal Health Corporation, informed the Company that she intends to resign from her position as Director of the Company effective April 15, 2026. Filing
  11. Feb 4, 2026ResultsReleased financial results. Filing
  12. Feb 3, 2026AnnouncementPhibro Animal Health Corporation issued a press release announcing the declaration of a quarterly cash dividend of $0.12 per share on its Class A common stock and Class B common stock, payable on March 25, 2026, to stockholders of record at the close of business on March 4, 2026. Filing
  13. Dec 18, 2025LeadershipPhibro Animal Health Corporation announced that Jack C. Bendheim, the current Chairman of the Board of Directors of the Company, Chief Executive Officer and President, will resign from his position as Chief Executive Officer and President, effective July 1, 2026. Filing

From 8-K reports, which a company must file within 4 business days of an important event. Where a report is about a change such as a new CEO, the sentence is the first one from the report itself, shortened. Each row links to the original filing. Company events this week

Phibro Animal Health financials

Famous investors that hold PAHC

4 of the 50 well-known investors we track reported holding PAHC in their latest 13F filing. The largest position is Israel Englander's, worth $29.4M.

Position size

All holders

FundQuarterSharesValueOf portfolioChange
Israel Englander · Millennium ManagementQ3 2026822,639$29.4M0.0%-12%
Jim Simons · Renaissance TechnologiesQ3 2026437,000$15.6M0.0%-9%
Ken Griffin · Citadel AdvisorsQ3 202672,654$2.6M0.0%+388%
Steve Cohen · Point72 Asset ManagementQ3 202636,493$1.3M0.0%New

From 13F reports: a snapshot at quarter end, filed up to 45 days later. Change compares with the quarter before.

5%+ stakes filed in the last 120 days

Anyone who owns more than 5% of a company must report it on Schedule 13D or 13G. 2 filings named PAHC in the last 120 days.

FiledHolderFormStake
Oct 19, 2026Millennium Management LLC13G/A3.9%
Oct 19, 2026Millennium Management LLC13G/A3.9%

Questions about Phibro Animal Health Corp (PAHC) stock

Who owns the most PAHC stock?

The largest reported owner of Phibro Animal Health Corp (PAHC) is BlackRock, Inc.. In total, 209 funds and institutions reported holding PAHC at the end of Q2 2026. See the largest owners.

Are PAHC insiders buying or selling?

In the last 12 months, PAHC insiders reported 1 open-market purchase worth $318K and 97 sales worth $24.6M. The latest trade was on May 29, 2026. See every trade.

What is the short interest in PAHC?

As of Oct 30, 2026, 1.02M PAHC shares were sold short, down 1.3% from the report before. At the average daily volume of 158,839 shares, buying them all back would take about 6.4 trading days (days to cover). See the history.

Which famous investors hold PAHC?

4 of the 50 well-known investors we track reported PAHC in their latest 13F filing, including Israel Englander, Jim Simons, Ken Griffin. The largest position is worth $29.4M. See all holders.

Executive pay

Phibro Animal Health's chief executive was paid a total of $5.2M for the year ended Jun 30, 2026, down 1% from $5.3M the year before. In the last 12 months, Phibro Animal Health's executives and directors bought $318K of stock on the open market and sold $12.4M.

Chief executive, total pay$5.2MYear ended Jun 30, 2026. Salary, bonus and the value of stock and option awards when granted.
Pay "actually paid"$5.2MThe same year, with stock awards valued at what they were worth as they vested or at year end.
Other top executives, average$1.5MThe other officers named in the proxy statement.

From the pay versus performance table in the company's annual proxy statement (DEF 14A), as the company reported it. If the chief executive changed during the year, the company reports each person separately and this shows one of them.

Source: SEC Form 4 (insiders, filed within 2 business days), 13F (funds, up to 45 days after quarter end) and Schedule 13D/13G filings. Only open-market purchases (code P) and sales (code S) are shown. Data only, not investment advice. How we collect it.